Propionibacterium acnes and sebaceous lipogenesis: A love-hate relationship?

Journal of Investigative Dermatology

Volumn 129, Issue 9, 2009, Pages 2093-2096

  Zouboulis, Christos C ^a,b  

^a DESSAU MEDICAL CENTER   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 2; INTERLEUKIN 6; INTERLEUKIN 8; LAURIC ACID; LIPID; OLEIC ACID; PALMITIC ACID; POLYPEPTIDE ANTIBIOTIC AGENT; PROSTAGLANDIN E2; TRIACYLGLYCEROL;

ACNE; ACNE VULGARIS; HUMAN; INFLAMMATION; INNATE IMMUNITY; LIPOGENESIS; NONHUMAN; NOTE; PRIORITY JOURNAL; PROPIONIBACTERIUM ACNES; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; SEBACEOUS GLAND; SKIN;

EID: 70349742410     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2009.190     Document Type: Note

References (53)

1. Alesci S, Bornstein SR (2000) Neuroimmuno-regulation of androgens in the adrenal gland and the skin. Horm Res 54:281-286
2. Alestas T, Ganceviciene R, Fimmel S, Müller-Decker K, Zouboulis CC (2006) Enzymes involved in the biosynthesis of leukotriene B4 and prostaglandin E2 are active in sebaceous glands. J Mol Med 84:75-87
3. Böhm M, Schiller M, Stander S, Seltmann H, Li Z, Brzoska T, Metze D et al. (2002) Evidence for expression of melanocortin-1 receptor in human sebocytes in vitro and in situ. J Invest Dermatol 118:533-539
4. Brown SK, Shalita AR (1998) Acne vulgaris. Lancet 351:1871-1876
5. Brüggemann H, Henne A, Hoster F, Liesegang H, Wiezer A, Strittmatter A et al. (2004) The complete genome sequence of Propionibacterium acnes, a commensal of human skin. Science 305:671-673
6. Chen W, Yang C-C, Sheu H-M, Seltmann H, Zouboulis CC (2003) Expression of peroxisome proliferator-activated receptor and CCAAT/ enhancer binding protein transcription factors in cultured human sebocytes. J Invest Dermatol 121:441-447
7. Coenye T, Honraet K, Rossel B, Nelis HJ (2008) Biofilms in skin infections: Propionibacterium acnes and acne vulgaris. Infect Disord Drug Targets 8:156-159
8. Delerive P, Fruchart J-C, Staels B (2001) Eurosterone Meeting-Peroxisome proliferator-activated receptors in inflammation control. J Endocrinol 169:453-459
9. Ganceviciene R, Fimmel S, Glass E, Zouboulis CC (2006) Psoriasin and follicular hyperkeratinization in acne comedones. Dermatology 213:270-272
10. Ganceviciene R, Graziene V, Böhm M, Zouboulis CC (2007) Increased in situ expression of melanocortin-1 receptor in sebaceous glands of lesional skin of patients with acne vulgaris. Exp Dermatol 16:547-552
11. Ganceviciene R, Graziene V, Fimmel S, Zouboulis CC (2009) Involvement of the corticotropin-releasing hormone system in the pathogenesis of acne vulgaris. Br J Dermatol 160:345-352
12. Georgel P, Crozat K, Lauth X, Makrantonaki E, Seltmann H, Sovath S et al. (2005) A TLR2-responsive lipid effector pathway protects mammals against Gram-positive bacterial skin infections. Infect Immun 73:4512-4521
13. Harrison WJ, Bull JJ, Seltmann H, Zouboulis CC, Philpott MP (2007) Expression of lipogenic factors galectin-12, resistin, SREBP-1, and SCD in human sebaceous glands and cultured sebocytes. J Invest Dermatol 127:1309-1317
14. Holmberg A, Lood R, Mörgelin M, Söderquist B, Holst E, Collin M et al. (2009) Biofilm formation by Propionibacterium acnes is a characteristic of invasive isolates. Clin Microbiol Infect; e-pub ahead of print 23 April 2009
15. Hong I, Lee MH, Na TY, Zouboulis CC, Lee MO (2008) LXRa enhances lipid synthesis in SZ95 sebocytes. J Invest Dermatol 128:1266-1272
16. Inuma K, Sato T, Akimoto N, Noguchi N, Sasatsu M, Nishijima S et al. (2009) Involvement of Propionibacterium acnes in the augmentation of ipogenesis in hamster sebaceous glands in vivo and in vitro. J Invest Dermatol 129:2113-2119
17. Wata C, Akimoto N, Sato T, Morokuma Y, Ito A (2005) Augmentation of lipogenesis by 15-deoxy-A1214-prostaglandin J2 in hamster sebaceous glands: identification of cytochrome P-450-mediated 15-deoxy-A1214-prostaglandin J2 production. J Invest Dermatol 125:865-867
18. Jarrousse V, Castex-Rizzi N, Khammari A, Charveron M, Dreno B (2007, Modulation of integrins and filaggrin expression by Propionibacterium acnes extracts on keratinocytes. Arch Derrnatol Res 299:441-7
19. Jugeau S, Tenaud I, Knol AC, Jarrousse V, Quereux G, Khammari A et al. (2005) Induction of toll-ike receptors by Propionibacterium acnes. Br J Dermatol 153:1105-1113
20. Kim J, Ochoa MT, Krutzik SR, Takeuchi O, Uematsu S, Legaspi AJ et al. (2002) Activation of Toll-ike receptor 2 in acne triggers inflammatory cytokine responses. J Immunol 169:1535-1541
21. Kliewer SA, Lenhard JM, Willson TM, Patel I, Morris DC, Lehmann JM (1995) A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor y and promotes adipocyte differentiation. Cell 83:813-819
22. Koreck A, Pivarcsi A, Dobozy A, Kemény L (2003) The role of innate immunity in the pathogenesis of acne. Dermatology 206:96-105
23. Krause K, Schnitger A, Fimmel S, Glass E, Zouboulis CC (2007) Corticotropin-releasing hormone skin signalling is receptor-mediated and is predominant in the sebaceous glands. Horm Metab Res 39:166-170
24. Lee D-Y, Yamasaki K, Rudsil J, Zouboulis CC, Park GT, Yang J-M et al. (2008) Sebocytes express functional cathelicidin antimicrobial peptides and can act to kill Propionibacterium acnes. J Invest Dermatol 128:1863-1866
25. Leyden JJ, McGinley KJ, Vowels B (1998) Propionibacterium acnes colonization in acne and nonacne. Dermatology 196:55-58
26. Ma H, Sprecher HW, Kolattukudy PE (1998) Estrogen-induced production of a peroxisome proliferator-activated receptor (PPAR) ligand in a PPARgamma-expressing tissue. J Biol Chem
27. McDowell A, Valanne S, Ramage G, Tunney MM, Glenn JV, McLorinan GC et al. (2005). Propionibacterium acnes types I and II represent phylogenetically distinct groups. J Clin Microbiol 43:326-334
28. McDowell A, Perry AL, Lambert PA, Patrick S (2008) A new phylogenetic group of Propionibacterium acnes. J Med Microbiol 57:218-224
29. Nagy I, Pivarcsi A, Koreck A, Széll M, Urbán E, Kemény L (2005) Distinct strains of Propionibacterium acnes induce selective human beta-defensin-2 and interleukin-8 expression in human keratinocytes through toll-like receptors. J Invest Dermatol 124:931-938
30. Nagy I, Pivarcsi A, Kis K, Koreck A, Bodai L, McDowell A et al. (2006) Propionibacterium acnes and lipopolysaccharide induce the expression of antibacterial peptides and proinflammatory cytokines/chemokines in human sebocytes. Microbes Infect 8:2195-2205
31. Nakatsuji T, Liu Y-T, Huang C-P, Zouboulis CC, Gallo RL, Huang C-M (2008) Antibodies elicited by inactivated Propionibacterium acnes-based vaccines exert protective immunity and attenuate the IL-8 production in human sebocytes: relevance to therapy for acne vulgaris. J Invest Dermatol 128:2451-2457 (correction: J Invest Dermatol 2009; 129:1590)
32. Nakatsuji T, Kao MC, Fang J-Y, Zouboulis CC, Zhang L, Gallo RL et al. (2009) Antimicrobial property of lauric acid against Propionibacterium acnes: its therapeutic potential for inflammatory acne vulgaris. J Invest Dermatol; doi:10.1038/ jid.2009.93
33. Neufang G, Furstenberger G, Heidt M, Marks F, Muller-Decker K (2001) Abnormal differentiation of epidermis in transgenic mice constitutively expressing cycooxygenase-2 in skin. Proc Natl Acad Sci USA 98:7629-7634
34. Oeff MK, Seltmann H, Hiroi N, Nastos A, Makrantonaki E, Bornstein SR et al. (2006) Differential regulation of Toll-like receptor and CD14 pathways by retinoids and corticosteroids in human sebocytes. Dermatology 213:266
35. Ottaviani M, Alestas T, Mastrofrancesco A, Flori E, Zouboulis CC, Picardo M (2006) Peroxidated squalene induces the production of inflammatory mediators in HaCaT keratinocytes-a possible role in acne vulgaris. J Invest Dermatol 126:2430-2437
36. Pivarcsi A, Bodai L, Réthi B, Kenderessy-Szabó A, Koreck A, Széll M et al. (2003) Expression and function of Toll-like receptors 2 and 4 in human keratinocytes. Int Immunol 15:721-730
37. Rosenfield RL, Kentsis A, Deplewski D, Ciletti N (1999) Rat preputial sebocyte differentiation involves peroxisome proliferator-activated receptors. J Invest Dermatol 112:226-232
38. Russell LE, Harrison WJ, Bahta AW, Zouboulis CC, Burrin JM, Philpott MP (2007) Characterization of liver X receptor expression and function in human skin and the pilosebaceous unit. Exp Dermatol 16:844-852
39. Schröder JM, Harder J (2006) Antimicrobial skin peptides and proteins. Cell Mol Life Sci 63:469-486
40. Slominski AT, Botchkarev V, Choudhry M, Fazal N, Fechner K, Furkert J et al. (1999) Cutaneous expression of CRH and CRH-R. Is there a "skin stress response system?" Ann NY Acad Sci 885:287-311
41. Thiboutot D, Sivarajah A, Gilliland K, Cong Z, Clawson G (2001) The melanocortin 5 receptor is expressed in human sebaceous glands and rat preputial cells. J Invest Dermatol 115:614-619
42. Trivedi NR, Cong Z, Nelson AM, Albert AJ, Rosamilia LL, Sivarajah S et al. (2006) Peroxisome proliferator-activated receptors increase human sebum production. J Invest Dermatol 126:2002-2009
43. Weindl G, Schäfer-Korting M, Schaller M, Korting H-C (2005) Peroxisome proliferator-activated receptors and their ligands-entry into the post-glucocorticoid era of skin treatment? Drugs 65:1919-1934
44. Wróbel A, Seltmann H, Fimmel S, Müller-Decker K, Tsukada M, Bogdanoff B et al. (2003) Differentiation and apoptosis in human immortalized sebocytes. J Invest Dermatol 120:175-181
45. Zhang L, Anthonavage M, Huang Q, Li WH, Eisinger M (2003) Proopiomelanocortin peptides and sebogenesis. Ann N Y Acad Sci 994:154-161
46. Zhang L, Li W-H, Anthonavage M, Eisinger M (2006a) Melanocortin-5 receptor: a marker of human sebocyte differentiation. Peptides 27:413-420
47. Zhang Q, Seltmann H, Zouboulis CC, Konger RL (2006b) Involvement of PPAR-gamma in oxidative stress-mediated prostaglandin E2 production in SZ95 human sebaceous gland cells. J Invest Dermatol 126:42-48
48. Zhang Q, Seltmann H, Zouboulis CC, Travers JB (2006c) Activation of platelet-activating factor receptor in SZ95 sebocytes results in inflammatory cytokine and prostaglandin E2 production. Exp Dermatol 15:769-774
49. Zouboulis CC (2001) Is acne vulgaris a genuine inflammatory disease? Dermatology 203:277-279
50. Zouboulis CC, Seltmann H, Neitzel H, Orfanos CE (1999) Establishment and characterization of an immortalized human sebaceous gland cell line (SZ95). J Invest Dermatol 113:1011-1020
51. Zouboulis CC, Seltmann H, Hiroi N, Chen W, Young M, Oeff M et al. (2002) Corticotropin releasing hormone: an autocrine hormone that promotes lipogenesis in human sebocytes. Proc Natl Acad Sci USA 99:7148-7153
52. Zouboulis CC, Nestoris S, Adler YD, Picardo M, Camera E, Orth M et al. (2003) A new concept for acne therapy: a pilot study with zileuton, an oral 5-lipoxygenase inhibitor. Arch Dermatol 139:668-670
53. Zouboulis CC, Eady A, Philpott M, Goldsmith LA, Orfanos C, Cunliffe WJ et al. (2005) What is the pathogenesis of acne? Exp Dermatol 14:143-152